Glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and advanced CKD: kidney and cardiovascular outcomes in a real-world setting
GLP-1 RAs were significantly associated with the incidence of kidney and cardiovascular events in patients with T2DM and advanced CKD, suggesting the potential importance of incorporating GLP-1 RA treatment to help modify disease progression and improve survival in this high-risk population.
Authors
- Ming‐Hsien Tsai (ORCID: https://orcid.org/0000-0003-3561-4689)
- Ching-Chung Hsiao (ORCID: https://orcid.org/0000-0003-3782-8189)
- Yu-Wei Fang
- Mon‐Ting Chen
- C.Y. Liu
- Chih-Yu Chan (ORCID: https://orcid.org/0009-0007-4267-3771)
- Hung‐Hsiang Liou
Institutions
- Fu Jen Catholic University (TW)
- Chang Gung University (TW)
- National Taipei University of Nursing and Health Science (TW)
- Jen-Ai Hospital (TW)
- Shin Kong WHS Memorial Hospital (TW)
- Memorial Hospital (US)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1093/ckj/sfaf172
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Shin Kong Wu Ho-Su Memorial Hospital